Generation of a dual edited human induced pluripotent stem cell Myl7-GFP reporter line with inducible CRISPRi/dCas9

Stem Cell Res. 2022 May:61:102754. doi: 10.1016/j.scr.2022.102754. Epub 2022 Mar 18.

Abstract

Temporal regulation of CRISPRi activity is critical for genetic screens. Here, we present an inducible CRISPRi platform enabling selection of iPSC-derived cardiomyocytes and reversible gene knockdown. We targeted a doxycycline-inducible dCas9-KRAB-mCherry cassette into the AAVS1 locus in an MYL7-mGFP reporter iPSC line. A clone with bi-allelic integration displayed minimally leaky CRISPRi activity and strong expression upon addition of doxycycline in iPSCs, iPSC-derived cardiomyocytes, and multilineage differentiated cells. The CRISPRi activity was validated by targeting the MYOCD gene in iPSC cardiomyocytes. In summary, we developed a robust inducible CRISPRi platform to interrogate gene function in human iPSC-derived cardiomyocytes and other cells.

MeSH terms

  • Cell Differentiation
  • Doxycycline / pharmacology
  • Gene Knockdown Techniques
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Transgenes

Substances

  • Doxycycline